Stock Screener
| # | Symbol | Price | Change % | Market Cap▼ | Volume | Name | 1 Week % | 1 Month % | 3 Month % | 6 Month % | 1 Year % | Equity Type | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101 | TRVI | 13.99 | +3.55 | 2.0B | 1.1M | Trevi Therapeutics, Inc. Common Stock | +2.72 | +17.56 | -25.63 | +5.67 | +26.72 | Common Stock | Biotechnology |
| 102 | FTRE | 20.37 | -0.63 | 2.0B | 521.6K | Fortrea Holdings Inc. Common Stock | +1.54 | -9.14 | +12.29 | +48.58 | +102.89 | Common Stock | Biotechnology |
| 103 | IMNM | 16.59 | -1.10 | 2.0B | 393.1K | Immunome, Inc. | -11.26 | -1.04 | -44.36 | -15.59 | -6.19 | Common Stock | Biotechnology |
| 104 | HRMY | 32.71 | -1.21 | 1.9B | 388.5K | Harmony Biosciences Holdings, Inc. Common Stock | -3.23 | -12.87 | -18.08 | +7.46 | -1.80 | Common Stock | Biotechnology |
| 105 | VERA | 26.45 | +3.40 | 1.9B | 593.7K | Vera Therapeutics, Inc. Class A Common Stock | -8.92 | -8.54 | -18.05 | -20.45 | -7.36 | Common Stock | Biotechnology |
| 106 | ZYME | 26.80 | +2.94 | 1.9B | 510.9K | Zymeworks Inc. | +1.27 | +4.95 | -1.49 | +9.86 | +18.61 | Common Stock | Biotechnology |
| 107 | BCRX | 7.29 | -0.20 | 1.9B | 2.0M | BioCryst Pharmaceuticals Inc | -5.14 | -9.73 | -27.66 | -16.93 | +5.12 | Common Stock | Biotechnology |
| 108 | REPL | 19.38 | -2.15 | 1.8B | 947.5K | Replimune Group, Inc. | -11.81 | +75.42 | +30.89 | +312.43 | +115.62 | Common Stock | Biotechnology |
| 109 | RARE | 17.32 | -2.34 | 1.8B | 1.2M | Ultragenyx Pharmaceutical Inc. | +6.42 | +14.90 | -34.01 | -22.87 | -45.65 | Common Stock | Biotechnology |
| 110 | STOK | 26.86 | +0.64 | 1.8B | 227.4K | Stoke Therapeutics, Inc. Common Stock | +2.52 | +8.22 | -18.68 | -10.35 | -5.69 | Common Stock | Biotechnology |
| 111 | AGIO | 29.02 | -2.21 | 1.7B | 216.3K | Agios Pharmaceuticals, Inc. | -8.61 | -16.83 | -17.36 | +4.67 | +29.92 | Common Stock | Biotechnology |
| 112 | VIR | 8.96 | -2.13 | 1.7B | 1.0M | Vir Biotechnology, Inc. Common Stock | -26.11 | -12.29 | -8.34 | +4.98 | +64.61 | Common Stock | Biotechnology |
| 113 | RXRX | 2.66 | -5.84 | 1.7B | 31.6M | Recursion Pharmaceuticals, Inc. Class A Common Stock | -20.12 | -26.32 | -24.00 | -6.67 | -33.99 | Common Stock | Biotechnology |
| 114 | URGN | 31.91 | +7.10 | 1.6B | 1.1M | UroGen Pharma Ltd. | +20.90 | -6.57 | -36.56 | +12.90 | +26.26 | Common Stock | Biotechnology |
| 115 | SRPT | 14.27 | -1.78 | 1.5B | 1.1M | Sarepta Therapeutics,, Inc. Common Stock | -10.86 | -19.50 | -27.66 | -14.23 | -12.92 | Common Stock | Biotechnology |
| 116 | NRIX | 13.69 | -2.92 | 1.5B | 1.0M | Nurix Therapeutics, Inc. Common stock | -12.25 | -45.09 | -50.74 | -10.18 | -4.47 | Common Stock | Biotechnology |
| 117 | PGEN | 4.09 | -4.21 | 1.5B | 2.7M | Precigen, Inc. Common Stock | -12.23 | -38.59 | -42.88 | -1.68 | -3.08 | Common Stock | Biotechnology |
| 118 | MESO | 11.15 | -4.21 | 1.4B | 187.2K | Mesoblast Limited | -14.88 | -6.70 | -34.91 | -23.37 | -24.92 | ADR | Biotechnology |
| 119 | ANAB | 47.63 | +1.21 | 1.4B | 271.8K | AnaptysBio, Inc. Common Stock | -0.29 | -3.27 | -19.62 | -20.31 | +28.70 | Common Stock | Biotechnology |
| 120 | QURE | 20.06 | -1.17 | 1.4B | 561.5K | uniQure N.V. | -18.54 | -9.63 | -58.85 | -18.74 | -28.22 | Common Stock | Biotechnology |